TEVA Jan 2025 15.000 call
| Previous close | 2.9900 |
| Open | 2.9000 |
| Bid | 2.9700 |
| Ask | 3.7500 |
| Strike | 15.00 |
| Expiry date | 2025-01-17 |
| Day's range | 2.9000 - 3.0000 |
| Contract range | N/A |
| Volume | |
| Open interest | 33.24k |
Business WireTeva Reaches Agreement With the Israel Tax Authority to Resolve All Pending Litigation for the Company's Taxable Years 2008-2020
TEL AVIV, Israel, June 25, 2024--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it has entered an agreement with the Israel Tax Authority (the "ITA") resolving all pending litigation with respect to taxes payable for the Company's taxable years 2008-2020. Under the terms of the agreement the Company will pay a total of $750 million in installments between 2024 to 2029.
Business WireTeva Announces Launch of Authorized Generic of Victoza® (liraglutide injection 1.8mg), in the United States
PARSIPPANY, N.J., June 24, 2024--Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced today the launch of an authorized generic of Victoza®1 (liraglutide injection 1.8mg), in the United States.
ZacksHere's Why You Should Consider Buying Alvotech (ALVO) Stock
Here, we discuss some reasons why buying Alvotech (ALVO) stock now may turn out to be a prudent move.
